![]() |
市场调查报告书
商品编码
1324865
手术量市场:现状分析与预测(2022-2028)Surgical Procedure Volume Market: Current Analysis and Forecast (2022-2028) |
由于全球需要手术的癌症发病率不断上升,全球外科手术量市场预计将以约 5.5 的复合年增长率大幅扩张。 例如,《美国癌症 2023》报告估计,女性中将有 297,790 例新的浸润性乳腺癌病例。 此外,还将诊断出 55,720 例新的乳腺导管癌 (DCIS) 病例。 在美国、加拿大和墨西哥等高收入国家,最常见的实体器官癌症,如乳腺癌和结直肠癌,更有可能被及早发现并通过手术切除控制在一个部位。肿瘤是有可能的。 此外,药物治疗和放射治疗相结合的辅助治疗已被证明具有潜在的治愈作用。 此外,切除癌组织是患者的首选治疗方法。
按类型划分,市场分为胃肠科、心血管科、眼科、妇科、泌尿科和美容科。 2021年全球市场将以心血管领域为主。 这是因为由于全世界人们久坐的生活方式,需要手术的心脏病的发病率正在增加。 例如,根据世界卫生组织 (WHO) 的数据,导致心脏病的最常见行为风险因素是不健康的饮食、缺乏体力活动、吸烟和有害使用酒精。 这些影响在个体中表现为血压升高、血糖水平升高、血脂升高以及超重或肥胖。 这些“中等风险因素”可以在初级保健机构中进行测量,并表明心脏病发作的风险增加。 此外,根据长寿报告,每年进行约 50,000 例心臟直视手术。 因此,上述因素预计将在预测期内推动市场增长。
市场细分将市场按渠道分为诊所和医院。 在预测期内,医院领域将主导市场增长。 这是由于拥有广泛的资源、专业设备和训练有素的工作人员。 此外,医院可提供从简单到復杂的多种手术方式,可开展心脏病、神经内科、妇科等多种手术。 例如,马萨诸塞州总医院是哈佛医学院最大的教学医院,以其专业外科项目而闻名,包括心臟外科、神经外科和骨科。 该医院每年进行20,000台手术。
为了更好地了解手术量的市场介绍,市场分为北美(美国、加拿大、北美其他地区)、欧洲(英国、德国、法国、意大利、西班牙、欧洲其他地区)、亚太地区(中国) 、日本、印度和亚太地区其他地区)以及世界其他地区。 预计亚太地区外科手术量市场在预测期内将以最高复合年增长率增长。 这是由于全球化和该地区医疗旅游业的增加。 从海外前往亚太地区接受医疗护理。 个人对该地区高质量医疗保健的认识不断提高、治疗成本低于发达国家以及先进医疗设备的可用性等因素正在推动该地区的医疗旅游业。 例如,根据2021年旅游部报告,2019年抵达印度的游客总数约为1090万人次,其中360万人次是医疗游客。 因此,亚太地区医疗旅游的兴起预计将在预测期内推动市场增长。
Surgical procedure volume refers to the surgical procedures performed by the surgeon in a definite amount of time. It is often used as a measure of the experience of a surgeon performing a particular surgery. Hence, an important consideration for the patient while choosing a particular surgeon or medical facility for surgery.
The global surgical procedure volume market is projected to expand significantly with a CAGR of ~5.5 owing to the rising incidence of cancer requiring surgery globally. For instance, according to the American Cancer, 2023 report, an estimated 297,790 new cases of invasive breast cancer would be diagnosed in women. About 55,720 new cases of ductal carcinoma in situ (DCIS) would be diagnosed. In high-income countries such as the US, Canada, and Mexico. the most common type of cancer for a solid organ such as the breast & colon is likely to be detected at an early stage, and surgical excision enables definitive locoregional control of the tumor contained in one area. Additionally, the combined adjuvant treatment with drugs and radiotherapy has proven to have promising curative potential. Further, the removal of the cancerous tissue is the preferred choice of treatment by the patients.
Based on type, the market is segmented into gastrointestinal, cardiovascular, ophthalmic, gynaecology, urology, and cosmetic. The cardiovascular segment dominates the global market in 2021. This is due to the rising incidence of heart disease requiring surgeries, owing to the sedentary lifestyle of people globally. For instance, according to the worlds health Organization (WHO), the most common behaviour risk factor contributing to heart disease are unhealthy food, physical inactivity, tobacco use and harmful use of alcohol. These effects may show up in individuals as raised blood pressure, raised blood glucose, raised blood lipids, and overweight and obesity. These "intermediate risk factors" can be measured in primary care facilities and indicate an increased risk of a heart attack. Furthermore, according to the lifespan report, approximately 50,000 open heart surgeries are performed each year. Thus, the above-mentioned factors are anticipated to boost market growth in the forecasting period.
Based on Channel, the market is segmented into physician clinics and hospitals. The hospital segment dominates the market growth during the forecast period. This is due to the availability of extensive resources, specialized equipment along with trained staff. Additionally, hospitals can offer a wide range of surgical procedures from simple to complex and can perform a wide range of surgery departments such as cardiology, neurology and gynaecology. For instance, Massachusetts General Hospital is the largest teaching hospital of Harvard medical school and is well known for its specialized surgical programme, including cardiac surgery, neurosurgery and orthopaedics. The hospital performs 20,000 surgeries every year.
For a better understanding of the market adoption of the surgical procedure volume, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (UK, Germany, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Rest of World. Asia-Pacific region market for surgical procedure volume market is anticipated to grow with the highest CAGR during the forecasting period. This is due to the globalization and rise in medical tourism in this region. Individuals from abroad travel to Asia-Pacific to receive medical treatment. Factors such as rising awareness amongst individuals for the high-quality medical treatment available in this region, low treatment cost than developed countries and availability of advanced medical equipment All these above-mentioned factors are driving medical tourism in this region. For instance, according to the Ministry of Tourism, 2021 report, the total no. of tourists arriving in India was around 10.9 million in 2019, out of which 3,60,000 were medical tourists. Thus, with the rise in medical tourism in the Asia-Pacific region, is anticipated to fuel market growth in the forecast period.
Some of the major players operating in the market include: CHRISTUS Health, AIIMS, New Delhi, Stanford Health Care., Healthcare Information and Management System Society Inc., The General Hospital Corporation., The Ottawa Hospital., Seoul National University Hospital, Appollo Hospital Enterprise Ltd. Fortis Healthcare., The Johns Hopkins Healthcare System Corporation